Is Eisai Co., Ltd. (ESAIY) a Buy, Sell, or Hold?
OTC : ESAIY
Eisai Co., Ltd.
$6.83 USD
$0.13 (1.94%)
- Volume
- 6.44K
- Average Volume
- 230.2K
- Market Capitalization
- $7.71B
- P/E Ratio
- 32.54
- Dividend Yield
- 3.60%
- Price Target
- Year High
- $9.22
- Year Low
- $5.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.17
- Current Ratio
- $2.24
Company Overview
OTC
Haruo Naito
Drug Manufacturers - Specialty & Generic
Healthcare
ESAIY
10543
JP
USD
Liquidity Metrics
0.21
2.24
1.48
0.72
1.17
Sales & Valuation
$825.38B
1.52
1.40
27.31
40.76
Profitability
$34.2
$38.56B
4.67%
6.18%
4.44%
2.66%
P/E Metrics
32.54
-1.97
-1.97
Analyst Price Target & Rating
3/5
0 Analysts
%
Poll Results
About Eisai Co., Ltd. (OTC:ESAIY) Stock
Eisai Co., Ltd. is a Japanese pharmaceutical firm deeply involved in the entire lifecycle of drug development, from initial research and innovation to manufacturing, distribution, and international trade within Japan. Its comprehensive product portfolio includes prominent medications such as Dayvigo, prescribed for insomnia, and the potent anticancer drug Lenvima, a molecularly targeted therapy effective against thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma when paired with everolimus. The company also markets Methycobal for peripheral neuropathy and Halaven, another anticancer agent targeting breast cancer. Further offerings encompass Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid formulation; Goofice and Movicol, utilized for managing chroni ... c constipation; Fycompa, an antiepileptic; Pariet, a proton-pump inhibitor; and Aricept, a treatment for Alzheimer's and Dementia with Lewy bodies. Additionally, it produces Chocola BB plus, a vitamin B2 supplement. Eisai maintains a strategic alliance with Bristol Myers Squibb, focusing on the joint development and commercialization of the antibody drug conjugate, farletuzumab ecteribulin. Established in Tokyo, Japan, in 1941, the company was initially known as Nihon Eisai Co., Ltd. before adopting its current name, Eisai Co., Ltd., in 1955.
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug
2026-07-13 15:02:12
The U.S. FDA on Monday approved an at-home starting dose of Eisai's and Biogen's Alzheimer's drug, allowing some patients to begin therapy with injections administered by themselves or a caregiver.
Eisai Co., Ltd. (ESAIY) Analyst/Investor Day Transcript
2026-05-25 10:47:04
Eisai Co., Ltd. (ESAIY) Analyst/Investor Day Transcript
Eisai Co., Ltd. (ESAIY) Q4 2026 Earnings Call Transcript
2026-05-15 12:50:46
Eisai Co., Ltd. (ESAIY) Q4 2026 Earnings Call Transcript
Merck-Eisai's combination cancer therapy fails to meet main goals of late-stage study
2026-04-21 06:53:05
Merck and Eisai's experimental combination treatments for a type of kidney cancer failed to meet the main goals of a late-stage study, the companies said on Tuesday.
Frequently Asked Questions
-
What is the current Eisai Co., Ltd. (ESAIY) stock price?
-
Eisai Co., Ltd.(OTC:ESAIY) stock price is $6.83 in the last trading session. During the trading session, ESAIY stock reached the peak price of $9.22 while $5.687 was the lowest point it dropped to. The percentage change in ESAIY stock occurred in the recent session was 1.94% while the dollar amount for the price change in ESAIY stock was $0.13.
-
ESAIY's industry and sector of operation?
-
The OTC listed ESAIY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of ESAIY?
-
Yanhui Feng | Senior Vice President
Terushige Iike | Executive VP, Rep. Corporate Officer & Chief Business Officer
Akiko Nakahama | Vice President of Japan Regulatory Affairs, Manufacturing, Quality & Technology
Takuya Oyama | Vice President, Chief Financial Officer & Chief IR Officer
Teiji Kimura | Head of Academia Industry Alliance, DHBL Office -
How many employees does ESAIY have?
-
Number of ESAIY employees currently stands at 10543. ESAIY operates from 4-6-10, Koishikawa, Tokyo, TY 112-8088, JP.
-
Link for ESAIY official website?
-
Official Website of ESAIY is: https://www.eisai.com
-
How do I contact ESAIY?
-
ESAIY could be contacted at phone #81 3 3817 3700 and can also be accessed through its website. ESAIY operates from 4-6-10, Koishikawa, Tokyo, TY 112-8088, JP.
-
How many shares of ESAIY are traded daily?
-
The average number of ESAIY shares traded daily for last 3 months was 230.2K.
-
What is the market cap of ESAIY currently?
-
The market value of ESAIY currently stands at $7.71B with its latest stock price at $6.83